Around one in six women (17 per cent) diagnosed with breast cancer go to their doctor with a symptom other…
Gold nanoparticles help deliver lethal one-two punch to cancer
'Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a…
Gut microbes linked to immunotherapy response in melanoma patients
'Patients with malignant melanoma – whose disease has spread – are more likely to respond to immunotherapy treatment if they…
Adult weight gain could increase cancer risk
'Substantial weight gain over many years increases the risk of obesity-related cancers in men by 50 per cent and in…
Understanding cancer worries could break down barriers to seeking help
'Recognising the reasons people worry about a potential cancer diagnosis could help ease concern and encourage people with possible cancer…
Brain tumour characteristics could help predict survival in people over 70
'Characteristics like seizures, location of the tumour, and pressure in the brain, give insight into length of survival and treatment…
Tumour cells in blood samples could predict prostate cancer spread
'Researchers have found a group of circulating tumour cells in prostate cancer patient blood samples which are linked to the…
CM-Path Hosts Industry Engagement Day
'On October 5th 2016, CM-Path invited industry representatives from pharmaceutical, molecular diagnostic and digital pathology companies to attend a workshop…
Clinical Trials trainee scheme a huge success
'The Clinical Trials Trainee Scheme was piloted with the NCRI Head & Neck CSG in 2013 and due to the…
NCRI Future of Surgery workshop report now available
'“Trials are only as credible as their endpoints.” The first NCRI Future of Surgery workshop took place in May…
NCRI’s CM-Path initiative successfully launched
'The launch of NCRI’s Cellular Molecular Pathology initiative (CM-Path) took place on 6 June. Funders, NCRI Partners, consumers and CM-Path…
NCRI Trustee, Professor Peter Johnson, recognised in Queen’s Birthday Honours 2016
'Professor Peter Johnson, NCRI Trustee and Cancer Research UK’s chief clinician has been awarded a CBE for services to Medicine…